Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extrathoracic mesothelial proliferations and their mimics.

Josep Lloreta-Trull1

  • 1Department of Pathology, Hospital del Mar-IMAS-IMIM, Universitat Pompeu Fabra, Barcelona, Spain. jlloreta@imas.imim.es

Ultrastructural Pathology
|March 7, 2006
PubMed
Summary

Diagnosing mesothelial proliferations can be challenging. While electron microscopy is definitive, immunohistochemistry is often used, but a specific marker for mesothelial differentiation is still needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bruce Mackay, MD, PhD, founding member of Society for Ultrastructural pathology: in memoriam - his legacy lives on.

Ultrastructural pathology·2026
Same author

Bruce Mackay, MD, PhD, founding member of Society for Ultrastructural pathology: in memoriam - his legacy lives on.

Ultrastructural pathology·2026
Same author

Muscle disease in severe COVID-19 patients: a microangiopathic myopathy.

Ultrastructural pathology·2025
Same author

Prognostic Value of PARP1 and PARP2 Copy Number Alterations in Prostate Cancer.

Laboratory investigation; a journal of technical methods and pathology·2025
Same author

Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer.

Virchows Archiv : an international journal of pathology·2023
Same author

SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence.

The Prostate·2021

Area of Science:

  • Pathology
  • Oncology
  • Histology

Background:

  • Mesothelial proliferations, both reactive and neoplastic, present diagnostic challenges.
  • Current diagnostic methods often rely on extensive immunohistochemistry panels.
  • A definitive, specific immunohistochemical marker for mesothelial differentiation is lacking.

Purpose of the Study:

  • To review the diagnostic difficulties in mesothelial proliferations.
  • To evaluate the utility and limitations of immunohistochemistry and electron microscopy.
  • To discuss differential diagnoses, particularly for peritoneal and testicular tumors.

Main Methods:

  • Review of literature on mesothelial proliferations.
  • Analysis of immunohistochemistry and electron microscopy findings.
  • Comparison with mimicking tumors in peritoneal and testicular sites.

Main Results:

  • Electron microscopy remains a gold standard for identifying mesothelial differentiation.
  • Immunohistochemistry panels are commonly employed but lack a single definitive marker.
  • Overlapping features in peritoneal and testicular tumors complicate diagnosis due to shared embryologic origins.

Conclusions:

  • Accurate diagnosis of mesothelial proliferations requires careful integration of light microscopy, immunohistochemistry, and electron microscopy.
  • Further research is needed to identify more specific markers for mesothelial tumors.
  • Understanding the differential diagnosis is crucial for appropriate patient management.

Related Experiment Videos